ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $87,000 | -92.8% | 1,536 | -94.4% | 0.00% | -90.5% |
| Q2 2021 | $1,212,000 | +46.7% | 27,536 | +64.4% | 0.02% | +50.0% |
| Q1 2021 | $826,000 | +184.8% | 16,746 | +142.7% | 0.01% | +180.0% |
| Q4 2020 | $290,000 | -8.2% | 6,900 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $316,000 | -8.7% | 6,900 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $346,000 | -2.5% | 6,900 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $355,000 | -16.7% | 6,900 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $426,000 | -19.5% | 6,900 | -21.6% | 0.01% | -10.0% |
| Q3 2019 | $529,000 | +677.9% | 8,800 | +1000.0% | 0.01% | +900.0% |
| Q2 2019 | $68,000 | -10.5% | 800 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $76,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |